Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors
Bijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
MedChemComm (2018) Vol. 9, Iss. 11, pp. 1871-1881
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Recent developments in molecular docking technology applied in food science: a review
Xuan Tao, Yukun Huang, Chong Wang, et al.
International Journal of Food Science & Technology (2019) Vol. 55, Iss. 1, pp. 33-45
Closed Access | Times Cited: 168
Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives
Genpeng Bai, Yiling Pan, Yuemei Zhang, et al.
Food Chemistry (2023) Vol. 429, pp. 136836-136836
Closed Access | Times Cited: 68
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
Bijo Mathew, Della Grace Thomas Parambi, Githa Elizabeth Mathew, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 11
Closed Access | Times Cited: 119
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 69
Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors
Ilaria D’Agostino, Githa Elizabeth Mathew, Paola Angelini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 986-993
Open Access | Times Cited: 37
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder
Sunil Kumar, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6908-6917
Open Access | Times Cited: 26
Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors
Della Grace Thomas Parambi, Jong‐Min Oh, Seung Cheol Baek, et al.
Bioorganic Chemistry (2019) Vol. 93, pp. 103335-103335
Closed Access | Times Cited: 60
Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds
Jae Pil Lee, Myung-Gyun Kang, Joon Yeop Lee, et al.
Bioorganic Chemistry (2019) Vol. 89, pp. 103043-103043
Closed Access | Times Cited: 58
Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg
Jeong Hyun Heo, Bo Hyun Eom, Hyung Won Ryu, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
Sachithra Thazhathuveedu Sudevan, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 20
Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?
Paolo Guglielmi, Simone Carradori, Alessandra Ammazzalorso, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 10, pp. 995-1035
Closed Access | Times Cited: 48
Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
Jong‐Min Oh, T. M. Rangarajan, Reeta Chaudhary, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2356-2356
Open Access | Times Cited: 46
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew, Jong‐Min Oh, Roua S. Baty, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 38855-38866
Open Access | Times Cited: 38
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
Rani Sasidharan, Bo Hyun Eom, Jeong Hyun Heo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 188-197
Open Access | Times Cited: 33
Synthesis, Characterization, Antibacterial and Antifungal Activities Evaluation of Metal Complexes With Benzaldehyde‐4‐methylthiosemicarbazone Derivatives
Amani Jaafar, Najwa Mansour, Adeline Fix‐Tailler, et al.
ChemistrySelect (2022) Vol. 7, Iss. 10
Closed Access | Times Cited: 26
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 29
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer’s Disease
Reeta Reeta, Seung Cheol Baek, Jae Pil Lee, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 8, pp. 643-654
Closed Access | Times Cited: 31
Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease
Changjun Zhang, Yangjing Lv, Renren Bai, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105070-105070
Closed Access | Times Cited: 26
Semicarbazones, thiosemicarbazone, thiazole and oxazole analogues as monoamine oxidase inhibitors: Synthesis, characterization, biological evaluation, molecular docking, and kinetic studies
Syeda Uroos Qazi, Asia Naz, Abdul Hameed, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105209-105209
Closed Access | Times Cited: 24
Inhibitory activity and mechanism of thiosemicarbazide derivatives on tyrosinase and their anti-browning activity in fresh apple juice
Zhiyun Peng, Jinfeng Zhang, Min He, et al.
International Journal of Biological Macromolecules (2024) Vol. 280, pp. 135631-135631
Closed Access | Times Cited: 2
Recent Advances in Synthesis and Medicinal Evaluation of 1,2‐Benzothiazine Analogues
Reetu Reetu, Raghuram Gujjarappa, Chandi C. Malakar
Asian Journal of Organic Chemistry (2022) Vol. 11, Iss. 8
Closed Access | Times Cited: 13
Design of enamides as new selective monoamine oxidase-B inhibitors
Fathima Sahla Kavully, Jong‐Min Oh, Sanal Dev, et al.
Journal of Pharmacy and Pharmacology (2020) Vol. 72, Iss. 7, pp. 916-926
Open Access | Times Cited: 19
Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease
Githa Elizabeth Mathew, Jong‐Min Oh, Kumar Mohan, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 13, pp. 4786-4794
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top